CTEPH News

Johnson & Johnson has completed its acquisition of Actelion, a company that develops pulmonary hypertension therapies, six months after the deal was announced in January. Actelion is now part of J&J’s Janssen Pharmaceuticals ... Read more

June 20, 2017June 23, 2017

New Pulmonary Hypertension Awareness Campaign Features Singer Traci Braxton

CTEPH News, News, PH News

A new Pulmonary Hypertension Association awareness campaign is featuring singer Traci Braxton, who has two sisters with related diseases. The public service ads, an extension of a previous awareness effort, are ... Read more

June 5, 2017June 5, 2017

Depression More Likely in Chronic Thromboembolic Pulmonary Hypertension Patients, Study Finds

CTEPH News, News

People with chronic thromboembolic pulmonary hypertension (CTEPH) are more likely to have a depressive temperament, finds a Japanese study, “Depressive Status in Patients With Chronic Thromboembolic Pulmonary Hypertension” that ... Read more

May 10, 2017May 10, 2017

New Surgery Simulator May Improve Lives of Canadians with Chronic Thromboembolic Pulmonary Hypertension

CTEPH News, News

The new pulmonary endarterectomy (PEA) surgery simulator — a 3D device developed by the National Research Council of Canada with support from Bayer — could potentially improve the lives of thousands of Canadians with chronic ... Read more

April 26, 2017April 26, 2017

One Type of Pulmonary Hypertension Is Under-diagnosed, Study Suggests

CTEPH News, News

A form of pulmonary hypertension known as chronic thromboembolic pulmonary hypertension may be under-diagnosed and under-treated, a review of research articles suggests. The study, “An epidemiological analysis of the ... Read more

March 31, 2017March 31, 2017

Pulmonary Thromboendarterectomy Should Be Considered for PH Before Transplant, Case Report Contends

CTEPH News, News, PH News

Chronic thromboembolic pulmonary hypertension (CTEPH) may be mitigated by pulmonary thromboendarterectomy, which prevents the need for lung transplant, a new case report shows. The study, “Pulmonary Thromboendarterectomy for Pulmonary ... Read more

March 27, 2017March 27, 2017

Blocking Factor in Lungs Could Be Way to Treat Clotting Form of Pulmonary Hypertension

CTEPH News, News, PH News

The discovery of a molecular factor that triggers blood clots in lung arteries may explain why chronic thromboembolic pulmonary hypertension (CTEPH) often occurs in patients without traditional clotting risk ... Read more

February 20, 2017February 20, 2017

Low Levels of Bad Cholesterol Associated with Increased Mortality in PAH, Study Suggests

CTEPH News, News, PAH News

Patients with pulmonary arterial hypertension (PAH) have low levels of low-density lipoprotein cholesterol (LDL-C) – or “bad cholesterol” – which is associated with an increased mortality risk, according to ... Read more

February 7, 2017February 7, 2017

PHA to Present Registry Data on Pulmonary Hypertension at Thoracic Society Meeting

CTEPH News, News, PAH News, PH News

The Pulmonary Hypertension Association (PHA) will present two abstracts with data from the PHA registry, which collects information on pulmonary hypertension (PH) patients diagnosed and evaluated at PHA-accredited centers with ... Read more

January 31, 2017January 31, 2017

Bayer and Merck Present Data on Adempas for PAH, CTEPH at Pulmonary Congress

CTEPH News, News, PAH News

Bayer and Merck recently presented positive results from five data sets that evaluated the clinical benefits of Adempas (riociguat) for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic ... Read more